Support
DONATE
DONATE
Vaccination Update March 2023: COVID Vaccination

Vaccination Update March 2023: COVID Vaccination

by | Mar 16, 2023

Vaccination Update March 2023: COVID Infections, such as pneumonia or COVID, can seriously impact on the symptoms experienced, quality of life and overall health of all patients with Neuroendocrine Cancer – particularly those with DIPNECH and/or a Lung Primary,...
The Impact of COVID-19 on the Management of NETS

The Impact of COVID-19 on the Management of NETS

by | Oct 17, 2022

INCA Supported a Study on the Impact of COVID-19 on NET Management, Now Published in the Journal of Neuroendocrinology An abstract of a study with the active involvement of the global neuroendocrine tumor (NET) community was published in the Journal of...
Cancer52 Showcase Video response to the Covid-19 pandemic

Cancer52 Showcase Video response to the Covid-19 pandemic

by | Oct 4, 2022

Delighted to launch the Cancer52 video showcasing the amazing work of Cancer52 members in response to the Covid-19 pandemic. The Showcase Video highlights the innovation and tenacity of our members in the face of the extraordinary challenges of the past couple of...
Neuroendocrine Cancer patient experience survey

Neuroendocrine Cancer patient experience survey

by | Jul 15, 2021

All Neuroendocrine Cancer patients globally are invited to share their experiences and perspectives on how treatment decisions have been modified during the COVID-19 pandemic for them via a specially designed survey. The survey is available in English, French, Italian...
NET CONNECT Survey

NET CONNECT Survey

by | May 27, 2021

NET CONNECT is a group of both established and next-generation international experts in the field of neuroendocrine tumours (NET).   The Steering Committee and Members aim to collaborate in scientific activities, share best practices and discuss the latest scientific...